MK0719
Phase 2Terminated 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pain, Postoperative
Conditions
Pain, Postoperative
Trial Timeline
Aug 1, 2006 → Jan 1, 2007
NCT ID
NCT00424424About MK0719
MK0719 is a phase 2 stage product being developed by Merck for Pain, Postoperative. The current trial status is terminated. This product is registered under clinical trial identifier NCT00424424. Target conditions include Pain, Postoperative.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00424424 | Phase 2 | Terminated |
Competing Products
20 competing products in Pain, Postoperative